screener
IEMG +2.7%: the sell signal on the emerging markets ETF enters its management phase
IEMG, the emerging markets ETF, rises 2.7% as its sell signal, now in week 5, enters the management phase. In our technical analysis the short is still 3.44% in profit, and the model suggests handling it with discipline.
IEFA +2.2%: sell signal in week 9, the short stays in its management phase
IEFA, the MSCI EAFE ETF, rises 2.2% on the week while its sell signal sits in week 9. In our model's technical analysis the trade is in its management phase, with the short still 1.12% in profit, a thin cushion.
IDEV +1.9%: the sell signal is in week 9 and the short is still in profit
IDEV, the international developed markets ETF, gains 1.9% while its sell signal sits in week 9. The trade is in its management phase, the short is still 1.02% in profit, and our model suggests running it with discipline.
IBM +0.9%: buy signal holds in week 11 as model coverage is complete
IBM stock gains 0.9% and the buy signal, now in week 11, holds 4.90% above entry. The model's coverage is complete, all 3 references are already reached, and our model does not suggest opening a new position.
Interactive Brokers +7.9%: the short stays 7.37% in profit in week 7
Interactive Brokers stock gains 7.9% while the sell signal, now in week 7, sits in its management phase. Our model shows the short still 7.37% in profit and suggests staying with the position already in place.
Hypera +1.6%: sell signal in week 3, model advises against a new short
In trading latinoamerica, Hypera stock gains 1.6% while the sell signal sits in week 3, with the short down 5.64%. Our model advises against opening a fresh short, since short selling on the signal has lost money on average.
HP +3.2%: sell signal enters its management phase, earnings due November 24
HP stock gains 3.2% and the sell signal, now in week 5, enters its management phase with the short 2.17% in profit. Our model flags the November 24 earnings report, which can bring wide price swings in either direction.
Honeywell +1.1%: the buy signal moves ahead, and our model points to a standard size
Honeywell stock gains 1.1%, and the buy signal, now in week 2, is 1.89% up since entry. Our model points to a standard position size, with the next scaling-out window coming in week 6 for 10% of the position.
Robinhood -3.8%: the sell signal enters its management phase, short up 21.25%
Robinhood stock falls 3.8% as the sell signal, now in week 5, enters its management phase. The short on this Nasdaq name is 21.25% in profit, and our model now puts the focus on protecting the gain already secured.
Thales +2.4%: the short stays 7.19% in profit in week 12 of the sell signal
Thales stock rises 2.4% on Euronext, while the sell signal, now in week 12, remains in its management phase. The short keeps a 7.19% gain, and our model suggests managing the trade with steady discipline.
Hims & Hers Health -24.1%: the short trade stands at +28.95% in week 16
Hims & Hers Health stock slides 24.1%, while the sell signal, now in week 16, stays in its management phase. Our model puts the short at a 28.95% gain and suggests managing the trade with discipline, step by step.
Hera +0.0%: at confirmation the model suggests a cautious lightening
Hera stock ends the week flat, while the buy signal moves into week 2, up 2.52% since entry. At the confirmation week our model rates the setup as weak and suggests a cautious lightening.
Home Depot +1.5%: buy signal 9.02% up, with earnings due on November 17
Home Depot stock gains 1.5% and the buy signal, now in week 3, is 9.02% up since entry. Our model indicates a standard position size, with the next scaling-out window in week 6, while earnings are due on November 17.
Halliburton +6.1%: a new sell signal fires, yet our model steers clear of shorts
Halliburton stock gains 6.1% on the week and triggers a new sell signal. Our model advises against opening a short: historically, short selling on the signal has lost money on average, since shares tend to rise over time.